Comparison of the Efficacy of Kinesio Taping and TENS Therapy in Patients With Cervical Myofascial Pain Syndrome

NCT07770308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-08-18

No results posted yet for this study

Summary

Cervical MPS is a condition of pain, weakness and loss of function caused by trigger points located in the tense bands in the muscles in the neck and upper back. Pharmacological and non-pharmacological treatments are used in the treatment of MPS. Although different treatment methods are used for MPS today, there is no proven treatment method to be superior to others. This study aimed to compare the effectiveness of exercise therapy, kinesiology taping and TENS therapy on pain, muscle strength and functional status in patients with cervical myofascial pain syndrome.

Conditions

  • Myofascial Pain Syndrome

Interventions

OTHER

home-based exercises

Exercise therapy is one of the most commonly used conservative treatment methods in the cervical MAS treatment protocol. Patients in the first group will be given trunk stabilization training, scapular adductor muscle strengthening, cervical posterior tilt, and stretching exercises for neck rotators, scalene muscles, levator scapula muscle, upper trapezius muscle, posterior cervical and suboccipital muscles. Among these exercises, it will be said that the strengthening exercises should be done in 2 sets of 30 repetitions a day, and the stretching exercises should be done in 2 sets of 10 repetitions. These exercises will be given as a home program and you will be asked to practice them every day for 4 weeks.

DEVICE

TENS

TENS is an electric current applied with superficial electrodes placed on the skin and used to relieve pain. Conventional (Traditional) TENS is the most commonly used type. It affects the transmission of pain on the gate control theory by affecting the thick, myelinated, afferent A alpha and beta fibers. The effect of conventional TENS begins in 30 minutes and disappears within approximately 2 hours after treatment is stopped. TENS will be applied to the patients in the second group with a Bio-Stim brand VH-1000 model TENS device in the form of symmetrical, biphasic quadrilateral pulses for 100 msec. Frequency is 60 Hertz (Hz), intensity will be adjusted according to the patient's perception of paresthesia. The negative electrode will be placed on the active trigger point on the upper trapezius muscle and the positive electrode on the acromial tendon. The total duration of the application will be 20 minutes and 1 session will be applied every day for two weeks, a total of 10 sessions.

DEVICE

kinesiology taping

Kinesiology taping has a wide range of indications, especially in the musculoskeletal system. It is used to protect against tissue damage in the musculoskeletal system and to treat existing injuries, injuries, pain and dysfunctions. Patients who receive kinesiology taping treatment will receive treatment six times in total for three weeks, with 3-day intervals. After the patient is allowed to sit comfortably on the chair, taping will be performed between the acromioclavicular joint and the C7 spinous process using the upper trapezius inhibition technique. In addition, a small kinesiological taping test will be applied to the patient's volar forearm as a rapid allergy screening test to prevent any dermatological allergic reaction.

Sponsors & Collaborators

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Principal Investigators

  • Sibel Çağlar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-03-15
Completion
2024-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07770308 on ClinicalTrials.gov